Skip to main content
Xavant's noninvasive neuromodulation device wins FDA clearance
8/2/2017

Xavant Technology obtained FDA clearance for its Stimpod NMS460, a noninvasive neuromodulation device designed for symptomatic relief and management of chronic intractable pain. The device, which includes nerve-locating technology, transcutaneously delivers a patented pulsed radiofrequency waveform to target areas.

Full Story: